This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

PrefixNamespace IRI
dcthttp://purl.org/dc/terms/
dbohttp://dbpedia.org/ontology/
n5https://covidontheweb.inria.fr:4443/about/id/entity/http/dbpedia.org/class/yago/
wdrshttp://www.w3.org/2007/05/powder-s#
yagohttp://dbpedia.org/class/yago/
rdfshttp://www.w3.org/2000/01/rdf-schema#
n10http://localhost:8890/about/id/entity/http/dbpedia.org/resource/
n4https://covidontheweb.inria.fr:4443/about/id/entity/http/dbpedia.org/resource/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
dbchttp://dbpedia.org/resource/Category:
xsdhhttp://www.w3.org/2001/XMLSchema#
wdhttp://www.wikidata.org/entity/
dbrhttp://dbpedia.org/resource/
Subject Item
dbr:Pembrolizumab
rdf:type
dbr:Antibody yago:OrganicCompound114727670 yago:Drug103247620 yago:Chemical114806838 yago:Compound114818238 wd:Q35120 wd:Q79529 wd:Q35758 dbo:Drug wd:Q8386 dbo:ChemicalSubstance
rdfs:label
Pembrolizumab Pembrolizumab Pembrolizumab Pembrolizumab
wdrs:describedby
n4:Cancer_immunotherapy n4:Cervical_cancer n5:Compound114818238 n10:The_New_York_Times n5:Chemical114806838 n4:Diabetic_ketoacidosis n5:OrganicCompound114727670 n4:Cell-mediated_immunity n5:Drug103247620 n10:Central_nervous_system n4:The_New_York_Times
dct:subject
dbc:Monoclonal_antibodies_for_tumors dbc:Experimental_cancer_drugs dbc:Antineoplastic_drugs dbc:Breakthrough_therapy
dbo:wikiPageWikiLink
dbr:Cancer_immunotherapy dbr:Diabetic_ketoacidosis dbr:Cell-mediated_immunity dbr:Central_nervous_system dbr:The_New_York_Times dbr:Cervical_cancer